SVRA vs XRAY · $1.11B cap vs rev $1.78B
Savara Inc (SVRA) versus Dentsply Sirona Inc (XRAY) — a side-by-side from cached financials, not a winner call.
Savara Inc (SVRA) is a biotechnology company listed on NASDAQ.
Dentsply Sirona Inc (XRAY) is a medical instruments & supplies company listed on NASDAQ.
SVRA does not have a complete income-statement cache yet.
Latest reported XRAY revenue for 2026-06-30 was $1.78B. Net income was $27.0M. XRAY currently screens at market cap $2.01B.
SVRA currently screens at market cap $1.11B. XRAY currently screens at market cap $2.01B.
Not investment advice. Open the SVRA and XRAY stock pages for the full models.
Not investment advice.